...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: from IR "Hepalink does not own Zenith shares."

RVX Investor Relations

12:21 PM (1 minute ago)
 
 
 
 
 
 
 
 
 
Hi xxxx,

Hepalink does not own Zenith shares.

Best regards,

Chris
Share
New Message
Please login to post a reply